tiprankstipranks
SCYNEXIS (SCYX)
NASDAQ:SCYX
US Market
SCYX
SCYNEXIS
RESEARCH TOOLSreports

SCYNEXIS (SCYX) Stock News & Sentiment

1,564 Followers
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
Premium
Company Announcements
SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
10d ago
8K
SCYX
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
Premium
Company Announcements
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
10d ago
8K
SCYX
SCYNEXIS Raises $40 Million in Strategic Private Placement
Premium
Company Announcements
SCYNEXIS Raises $40 Million in Strategic Private Placement
10d ago
8K
SCYX
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
Premium
Ratings
Buy Rating on Scynexis Backed by Strong Cash Runway and Differentiated Next‑Generation Antifungal SCY‑247 Opportunity
22d ago
SCYX
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
Premium
Company Announcements
SCYNEXIS Halts Phase 3 MARIO Trial, Raising New Questions for Ibrexafungerp’s Growth Path
4M ago
SCYX
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
Premium
Ratings
SCYNEXIS: Strong Financial Position and Promising Antifungal Pipeline Drive Buy Rating
5M ago
SCYX
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
Premium
Company Announcements
SCYNEXIS Reports Q3 2025 Financial Results and Strategic Updates
5M ago
SCYX
More SCYX News >

SCYX News on the Web

SCYNEXIS Acquires SCY-770, Refocuses on Rare Kidney Disease
TipRanks News
Neutral
SCYNEXIS Inc Corporate Update Call Transcript
GuruFocus News
Neutral
SCYNEXIS Acquires AMPK Program, Expands Rare Disease Pipeline
TipRanks News
Neutral
SCYNEXIS Raises $40 Million in Strategic Private Placement
TipRanks News
Neutral
SCYNEXIS Secures Rights to PXL770 in a Deal Worth Up to $196 Million—Major Milestone for Rare Kidney Disease Pipeline
Market Chameleon
Neutral
Poxel To Sell PXL770 To Scynexis For Up To $196 Mln; Shares Up
rttnews
Bullish
Poxel announces sale of PXL770 to Scynexis for up to $196M
TipRanks News
Neutral
Scynexis completes acquisition of PXL-770 for treatment of kidney disease
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SCYX’s Media Buzz Sentiment?
Currently, no data Available
What is SCYX’s weekly average amount of articles?
Currently, no data Available
What is SCYX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
NBIXNeurocrine
STAAStaar Surgical
AORTArtivion
OWLTOwlet
HUMHumana
Showing the stocks with the most bullish news sentiment over the past week